logoOmicsDI
  • Browse
  • Submit Data
  • Databases
  • API

4 Results

Show all   Save search   Copy query

Show results for

  • UnknownUnknown (4)

Publication Date

Release Date

  • Previous page
  • 1 / 1
  • You're on page 1
  • Next page
Sort   by:  
Relevance
 Page size 
10
UnknownA Phase 2 Randomized Controlled Multisite Study Using Omalizumab-facilitated Rapid Desensitization to Test Continued vs Discontinued Dosing in Multifood Allergic Individuals.
Not available
S-EPMC6537534 | biostudies-literature
UnknownObservational long-term follow-up study of rapid food oral immunotherapy with omalizumab.
Not available
S-EPMC5738812 | biostudies-literature
UnknownFeasibility of sustained response through long-term dosing in food allergy immunotherapy.
Not available
S-EPMC5738818 | biostudies-literature
UnknownOrigins and clonal convergence of gastrointestinal IgE+ B cells in human peanut allergy.
Not available
S-EPMC7691169 | biostudies-literature
  • Previous page
  • 1 / 1
  • You're on page 1
  • Next page
Sort   by:  
Relevance
 Page size 
10
OmicsDI is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

EMBL-EBI logoEMBL-EBI logo

OmicsDI Databases

  • PRIDE
  • PeptideAtlas
  • MassIVE
  • JPOST Repository
  • Physiome Model Repository
  • EGA
  • EVA
  • ENA
  • LINCS
  • PAXDB
  • Cell Collective
  • MetaboLights
  • Metabolomics Workbench
  • MetabolomeExpress
  • GNPS
  • BioModels
  • FAIRDOMHub
  • ArrayExpress
  • dbGaP
  • ExpressionAtlas
  • GEO
  • NODE

Information

  • Databases
  • Help
  • API
  • Contact us
  • Code on GitHub
  • Terms of use
  • Submit Data